巨细胞动脉炎患者复发症状的一致性研究
该研究分析了三个巨细胞动脉炎队列共510例患者,评估初诊、首次复发和第二次复发之间症状的一致性。结果显示5年首次复发率为66%,第二次复发率为36%;约20%的患者复发时出现基线不存在的症状类别。基线大血管受累预示复发时大血管受累风险更高,既往有视觉症状者复发时视觉症状风险高,而既往无颅或视觉症状者该风险低。
要点
- 5年首次复发率66%(95%CI 60-70%),第二次复发率36%(95%CI 31-41%)。
- 约20%的患者复发时出现基线不存在的症状类别。
- 基线大血管受累者首次和第二次复发时大血管受累风险更高。
核心结论
- 患者和医疗提供者应接受关于巨细胞动脉炎症状谱的教育,以便识别初诊表现之外可能出现的症状。
研究设计与样本
- 分析三个巨细胞动脉炎队列:活检证实且未接受托珠单抗治疗的286例队列(C1)、活检阴性且未接受托珠单抗治疗的110例队列(C2)、活检或影像证实且接受托珠单抗治疗的114例队列(C3),以及三者汇总队列(C4)。
- 共纳入510例诊断为巨细胞动脉炎的患者(C4),中位随访5.3年(四分位距3.1-8.7年)。
主要发现
- 303例患者至少经历1次复发(5年首次复发率66%;95%CI 60-70%),160例经历至少2次复发(5年第二次复发率36%;95%CI 31-41%)。
- 约20%的患者复发时出现基线不存在的症状类别。
- 基线大血管受累提供首次和第二次复发时大血管受累的更高风险。
- 若既往阶段存在视觉症状,则首次或第二次复发时视觉症状风险高;若既往阶段无颅或视觉症状,则复发时该风险低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate concordance of symptoms between initial presentation, first relapse, and second relapse in patients with giant cell arteritis (GCA). METHODS: We analyzed three GCA cohorts: a 286-patient biopsy-proven cohort treated without tocilizumab (C1), a 110-patient biopsy-negative cohort treated without tocilizumab (C2), a 114-patient biopsy- or imaging-proven cohort that was treated with tocilizumab (C3), and an aggregate of these three cohorts (C4). We calculated odds ratios and conditional probabilities to evaluate concordance of symptoms from baseline presentation features to first relapse, baseline presentation to second relapse, and first relapse to second relapse. RESULTS: The study included a total of 510 patients (C4) diagnosed with GCA who were followed for a median of 5.3 (inter-quartile range: 3.1-8.7) years. Overall, 303 patients experienced at least 1 relapse (5-year first relapse rate 66%; 95% confidence interval [CI]: 60-70%) and 160 experiencing at least 2 relapses (5-year second relapse rate: 36%; 95% CI: 31-41%). Approximately 20% of patients relapsed with a symptom category that was absent at baseline. Baseline large vessel (LV) involvement provided higher risk of LV involvement on first and second relapse. Risk of visual symptoms on either first or second relapse was high if present at a previous stage, but low if either cranial or visual symptoms were absent at a previous stage. CONCLUSION: Patients and providers should be educated on the spectrum of GCA symptoms to be aware of, even beyond those present at a patient's initial presentation.
引用
- Guarda M, Hanson AC, Langenfeld HE, et al. Concordance of relapse symptoms in patients with giant cell arteritis. Semin Arthritis Rheum. 2025. PMID: 40876384. doi:10.1016/j.semarthrit.2025.152814
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。